Candriam Equities L Biotech.I GBP Acc/ LU1269737059 /
| NAV2024-04-24 | Chg.-9.7500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 3,280.1299GBP | -0.30% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 1.64 | 6.04 | -0.12 | 13.33 | -1.09 | 4.68 | -6.72 | 6.19 | -1.75 | - |
| 2017 | 3.79 | 8.04 | -0.55 | -2.13 | -2.82 | 8.54 | 1.05 | 8.83 | -3.11 | -5.36 | -1.59 | 1.59 | +16.06% |
| 2018 | 1.61 | -1.63 | -3.64 | -1.30 | 8.37 | 1.78 | 5.19 | 5.17 | -2.34 | -12.18 | 4.36 | -8.08 | -4.56% |
| 2019 | 9.61 | 2.35 | 1.48 | -4.90 | -1.46 | 8.35 | 1.42 | -1.75 | -5.56 | 5.58 | 11.94 | 0.07 | +28.66% |
| 2020 | -4.76 | 2.04 | -2.16 | 10.91 | 11.53 | 1.46 | -8.51 | -1.07 | 4.34 | -2.82 | 6.39 | 0.66 | +17.29% |
| 2021 | 1.42 | -4.25 | -2.92 | 2.44 | -4.49 | 9.25 | -2.01 | 5.05 | -2.18 | -1.72 | -0.76 | -0.59 | -1.63% |
| 2022 | -9.93 | -1.98 | 7.73 | -3.11 | -3.70 | 6.91 | 4.41 | 5.70 | 2.20 | 3.71 | 2.65 | -3.74 | +9.66% |
| 2023 | 0.63 | -4.09 | -1.65 | 0.61 | 0.20 | -1.29 | -1.32 | 1.37 | -0.65 | -5.57 | 1.60 | 12.72 | +1.50% |
| 2024 | 1.44 | 2.04 | 0.19 | -4.77 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.79% | 18.47% | 16.34% | 20.74% | 23.50% |
| Sharpe ratio | -0.47 | 0.98 | -0.09 | -0.02 | 0.20 |
| Best month | +12.72% | +12.72% | +12.72% | +12.72% | +12.72% |
| Worst month | -4.77% | -5.57% | -5.57% | -9.93% | -9.93% |
| Maximum loss | -9.21% | -9.21% | -11.90% | -21.19% | -23.19% |
| Outperformance | -3.11% | - | -0.37% | - | - |
All quotes in GBP
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,943.7300 | +2.27% | +0.54% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 210.9900 | +5.17% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 1,949.3500 | 0.00% | -6.46% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,121.0901 | +5.45% | +13.29% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,280.1299 | +2.41% | +10.79% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 345.0800 | +3.12% | +14.58% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 311.0900 | +6.15% | +15.92% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 190.8100 | -1.68% | -7.53% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,743.4100 | +3.13% | +3.31% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 141.6200 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 567.4900 | +1.60% | -1.20% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,318.0000 | +2.15% | +0.17% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 187.0400 | -0.18% | -6.61% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 194.9200 | +0.68% | -4.32% | |
| Candriam Equities L Biotech.R US... | reinvestment | 252.7500 | +2.87% | +2.54% | |
| Candriam Equities L Biotech.C US... | reinvestment | 796.3700 | +1.97% | +0.05% | |
| Candriam Equities L Biotech.C US... | paying dividend | 731.5500 | +1.94% | -0.04% |
Performance
| YTD | -1.23% | ||
|---|---|---|---|
| 6 Months | +10.38% | ||
| 1 Year | +2.41% | ||
| 3 Years | +10.79% | ||
| 5 Years | +50.77% | ||
| Since start | +118.68% | ||
| Year | |||
| 2023 | +1.50% | ||
| 2022 | +9.66% | ||
| 2021 | -1.63% | ||
| 2020 | +17.29% | ||
| 2019 | +28.66% | ||
| 2018 | -4.56% | ||
| 2017 | +16.06% | ||
